Drug Shortage Report for METRONIDAZOLE INJECTION, USP

Last updated on 2024-02-08 History
Report ID 218656
Drug Identification Number 00870420
Brand name METRONIDAZOLE INJECTION, USP
Common or Proper name Metronidazole Injection
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) METRONIDAZOLE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100 mL (JB3401P)
ATC code J01XD
ATC description OTHER ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-02-06
Actual start date 2024-02-06
Estimated end date 2024-02-14
Actual end date 2024-02-07
Shortage status Resolved
Updated date 2024-02-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-02-08 English Compare
v5 2024-02-07 French Compare
v4 2024-02-07 English Compare
v3 2024-02-07 English Compare
v2 2024-02-06 French Compare
v1 2024-02-06 English Compare

Showing 1 to 6 of 6